ÐÇ¿ÕÓéÀÖ¹ÙÍø

Published in Morbidity and Mortality Weekly Report (MMWR)

The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the ÐÇ¿ÕÓéÀÖ¹ÙÍø regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the ÐÇ¿ÕÓéÀÖ¹ÙÍø Director and, if adopted, are published as official ÐÇ¿ÕÓéÀÖ¹ÙÍø/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).

CURRENT MMR vaccine recommendations

MMWR, November 18, 2022, Vol 71(46);1465–70
Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
Print version

MMWR, January 12, 2018, Vol 67(1);33–38
Recommendations of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak
Print version

MMWR, June 14, 2013, Vol 62(RR-04);1-34
Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 Summary: Recommendations of the ACIP
Print version

See also:
MMRV ACIP Recommendations (includes varicella)

ARCHIVED historical MMR immunization publications

For your convenience, these archived publications can be used for historical and research purposes.

MMWR, June 9, 2006, Vol 55(22);629-630
Notice to Readers: Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP) for the Control and Elimination of Mumps
Print version

MMWR, December 14, 2001, Vol 50(49);1117
Notice to Readers: Revised ACIP Recommendation for Avoiding Pregnancy After Receiving a Rubella-Containing Vaccine
Print version

MMWR, May 22, 1998, Vol 47(RR-8);1-57
MMR—Vaccine Use and Strategies for Elimination of Measles, Rubella, and Congenital Rubella Syndrome and Control of Mumps
Print version